Prot# TFP008: A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind, 3-Arm Study to Evaluate the Safety & Efficacy of Tifacogin(Recombinant Tissue Factor Pathway Inhibitor) Administration in Subjects w/Severe Community-Acquired Pneumonia